TAVR

Transcatheter aortic valve replacement (TAVR) is a key structural heart procedure that has rapidly expanded in the decade since it was first FDA cleared. TAVR has come a paradigm shift in how many aortic stenosis patients are treated, now making up more than 50% of U.S. aortic valve replacements. It is less invasive than open heart surgery and recovery times are greatly reduced. TAVR can also be used in patients who otherwise are too high risk to undergo surgery. TAVR is referred to as transcatheter aortic valve implantation (TAVI) in many placed outside of the U.S. TAVR inspired the growing areas of transcatheter mitral repair or replacement and transcatheter tricuspid valve repair and replacement.

Thumbnail

Conscious sedation associated with better TAVR outcomes than general anesthesia

The use of conscious sedation during transcatheter aortic valve replacement is associated with better patient outcomes, including a decrease in mortality, than general anesthesia.

Thumbnail

TAVR ‘a viable option’ for patients with bicuspid valve disease

TAVR is a safe, effective treatment for patients with bicuspid valves, according to research published in JACC: Cardiovascular Interventions.

Thumbnail

New Data Underscore Importance of Looking for HCM Before Scheduling TAVR

Reported in 2018 by anesthesiologists at the University of Florida College of Medicine in Gainesville, the case suggested a message to TAVR operators: “Vigilance and a high degree of suspicion” are critical for avoiding the potentially severe hemodynamic consequences of HCM associated with aortic stenosis, the authors asserted (J Med Case Rep 2018;18;12[1]:372).

Study reveals similar 5-year outcomes for TAVR, SAVR

An analysis of PARTNER 2 data published in the New England Journal of Medicine Jan. 29 suggests five-year post-op outcomes are similar among heart patients who undergo either transcatheter or surgical aortic valve replacement.

Thumbnail

Cardiology’s Challenge for the 2020s: Turning the Trend on Rising Mortality

The latest numbers on cardiovascular deaths put the focus on innovative ways to point the trend line down again.

Thumbnail

TAVR linked to better long-term health status than SAVR

Patients with severe aortic stenosis who undergo TAVR enjoy a minor but significant sustained health benefit that isn’t mirrored in patients who opt for surgical AVR, according to research reported at TCT 2019 in San Francisco.

Thumbnail

Transcarotid Access: The Future of Non-femoral TAVR?

The transcarotid approach to TAVR is becoming more common, according to research presented at TVT.19.

Thumbnail

SCCT shares updated guidance on CT use during TAVI, TAVR procedures

The Society of Cardiovascular Computed Tomography (SCCT) has issued an updated guidance for the use of CT in transcatheter aortic valve implantation (TAVI) and transcatheter aortic valve replacement (TAVR) procedures. The full document can be read in the Journal of Cardiovascular Computed Tomography.